A Surprising Sleep Discovery in Microdosing research published in Nature's Translational Psychiatry

Apr 23, 2024 5:12 am

Hi


It was a surprising discovery in a randomized controlled trial testing microdoses of LSD (MB22001) in 80 healthy people. The data shows a statistically significant improvement in sleep, including total time of sleep and quality of sleep with some surprising nuances!


A credit to incredible scientists working on the MindBio clinical trials program, their sleep research has been published in the prestigious Nature portfolio journal Translational Psychiatry.


image

Click to Video!


Notably, on dose days, clinical trial participant's sleep was not effected yet they reported statistically significant subjective improvements in mood including energy, wellness, happiness, social connection and creativity. They also felt less irritable and less angry on dose days.


In this trial, however it was the day after dose days where sleep becomes relevant because there was a surprising and statistically significant increase in total sleep time of 24 minutes and an increase in REM sleep time of 8 minutes.


The implications for sleep research and for developing treatments for mental health conditions where sleep is often disrupted is significant.


For those of you who love sifting through and critiquing the data. Here is a link to the paper: https://www.nature.com/articles/s41398-024-02900-4


For those more visual folks, we discuss the results and the broader implications in the following video here:

Watch the video




Stay Well!


Justin Hanka

Chief Executive Officer

MindBio Therapeutics Corp (Frankfurt: WF6), (CNSX: MBIO)

Follow CEO Justin Hanka on LinkedIn:

https://www.linkedin.com/in/justinhanka/

Follow MindBio on LinkedIn: https://www.linkedin.com/company/mindbio-therapeutics/?viewAsMember=true




Comments